Sterling Investment Advisors (Pennsylvania)’s Allergan Inc AGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-81
| Closed | -$14K | – | 460 |
|
|
2020
Q1 | $14K | Hold |
81
| – | – | 0.01% | 298 |
|
|
2019
Q4 | $15K | Hold |
81
| – | – | 0.01% | 322 |
|
|
2019
Q3 | $14K | Hold |
81
| – | – | 0.01% | 323 |
|
|
2019
Q2 | $14K | Hold |
81
| – | – | 0.01% | 331 |
|
|
2019
Q1 | $12K | Hold |
81
| – | – | 0.01% | 331 |
|
|
2018
Q4 | $10K | Sell |
81
-110
| -58% | -$13.6K | 0.01% | 332 |
|
|
2018
Q3 | $36K | Hold |
191
| – | – | 0.02% | 259 |
|
|
2018
Q2 | $31K | Hold |
191
| – | – | 0.02% | 254 |
|
|
2018
Q1 | $32K | Sell |
191
-110
| -37% | -$18.4K | 0.02% | 251 |
|
|
2017
Q4 | $49K | Hold |
301
| – | – | 0.03% | 191 |
|
|
2017
Q3 | $62K | Sell |
301
-92
| -23% | -$18.9K | 0.04% | 164 |
|
|
2017
Q2 | $96K | Hold |
393
| – | – | 0.06% | 138 |
|
|
2017
Q1 | $94K | Hold |
393
| – | – | 0.07% | 133 |
|
|
2016
Q4 | $83K | Buy |
+393
| New | +$83K | 0.07% | 130 |
|
Sterling Investment Advisors (Pennsylvania)'s AGN Position: Q2 2020 in Review
Sterling Investment Advisors (Pennsylvania) sold out of Allergan Inc (AGN) in Q2 2020, closing a stake of 81 shares — an estimated $14K sold.
Sterling Investment Advisors (Pennsylvania) first reported a position in AGN in Q4 2016 and held it in 14 quarters. The position peaked at $96K in Q2 2017. 0 funds tracked by Wall St. Rank hold AGN as of Q2 2020.
- Sterling Investment Advisors (Pennsylvania) reported no remaining Allergan Inc position as of Q2 2020 after selling out during the quarter.
- Sterling Investment Advisors (Pennsylvania) sold 81 Allergan Inc shares in Q2 2020, an estimated $14K.
- Sterling Investment Advisors (Pennsylvania) first reported a position in Allergan Inc in Q4 2016 and held it in 14 quarters.
- Sterling Investment Advisors (Pennsylvania)'s Allergan Inc position peaked at $96K in Q2 2017.
- 0 funds tracked by Wall St. Rank held Allergan Inc as of Q2 2020.
Based on Sterling Investment Advisors (Pennsylvania)'s 13F filing for Q2 2020, filed 24 Jul 2020.